SMR14 Antibody

Potential Nomenclature Confusion

The term "SMR14" does not align with established antibody naming conventions (e.g., WHO’s INN system) or UniProt/Swiss-Prot identifiers. Closest matches include:

2.1. MRP14 (S100A9)

• Structure: Forms heterodimers with MRP8 (S100A8). Binds divalent cations (Zn²⁺, Ca²⁺) via EF-hand motifs .

• Function:

  • Antimicrobial activity via cation chelation .

  • Enhances neutrophil extracellular trap (NET) efficacy against Klebsiella pneumoniae .

  • Plasma levels correlate with sepsis severity .

2.2. LSm14A Antibodies

• Role: Mediates antiviral responses by sensing viral RNA/DNA and activating IRF3/IFN-β pathways .

• Key Data:

  • Knockdown reduces IFN-β production by 60–80% during RNA/DNA virus infection .

  • Localizes to peroxisomes post-viral infection to coordinate RIG-I/MITA signaling .

2.3. AM14 Antibody

• Target: Prefusion conformation of RSV F glycoprotein.

• Properties:

  • Neutralizes RSV A/B subtypes with IC₅₀ < 1 nM .

  • Binds quaternary epitopes spanning two protomers (K_D = 0.18 nM) .

  • Fails to recognize postfusion F or monomeric forms .

3.2. Challenges in Identifying "SMR14"

• Nomenclature: "SMR" may refer to "Small Mutant Related" or "Splicing/RNA-binding Motif," but no standardized definition exists.

• Validation: Antibodies require enhanced validation (e.g., siRNA knockdown, independent epitope confirmation) to confirm specificity .

Recommendations for Further Research

1. Clarify Target Identity: Verify if "SMR14" refers to a novel target, a typographical error, or an uncharacterized epitope.

2. Explore Homologs: Investigate antibodies against structurally similar proteins (e.g., MRP14, LSm14A) for cross-reactivity studies.

3. Utilize Phage Display/AI Design: Leverage computational methods for de novo antibody development if "SMR14" is a new antigen .